Idarubicin-loaded ONCOZENE drug-eluting embolic agents for chemoembolization of hepatocellular carcinoma: in vitro loading and release and in vivo pharmacokinetics.

PURPOSE: To present in vitro loading and release characteristics of idarubicin with ONCOZENE (CeloNova BioSciences, Inc, San Antonio, Texas) drug-eluting embolic (DEE) agents and in vivo pharmacokinetics data after transarterial chemoembolization with idarubicin-loaded ONCOZENE DEE agents in patients with hepatocellular carcinoma. MATERIALS AND METHODS: Loading efficacy of idarubicin with ONCOZENE DEE agents 100 µm and DC Bead (Biocompatibles UK Ltd, Farnham, United Kingdom) DEE agents 100-300 µm was monitored at 10, 20, and 30 minutes loading time by high-pressure liquid chromatography. A T-apparatus was used to monitor the release of idarubicin from the two types of DEE agents over 12 hours. Clinical and 24-hour pharmacokinetics data were recorded after transarterial chemoembolization with idarubicin-loaded ONCOZENE DEE agents in four patients with unresectable hepatocellular carcinoma. RESULTS: Idarubicin loading in ONCOZENE DEE agents was > 99% at 10 minutes. Time to reach 75% of the release plateau level was 37 minutes ± 6 for DC Bead DEE agents and 170 minutes ± 19 for ONCOZENE DEE agents both loaded with idarubicin 10 mg/mL. After transarterial chemoembolization with idarubicin-loaded ONCOZENE DEE agents, three partial responses and one complete response were observed with only two asymptomatic grade 3 biologic adverse events. Median time to maximum concentration for idarubicin in patients was 10 minutes, and mean maximum concentration was 4.9 µg/L ± 1.7. Mean area under the concentration-time curve from 0-24 hours was equal to 29.5 µg.h/L ± 20.5. CONCLUSIONS: ONCOZENE DEE agents show promising results with very fast loading ability, a favorable in vivo pharmacokinetics profile with a sustained release of idarubicin during the first 24 hours, and encouraging safety and responses. Histopathologic and clinical studies are needed to evaluate idarubicin release around the DEE agents in tumor tissue and to confirm safety and efficacy.

Combined report on the institutions under the control of the Iowa Department of Corrections for the five years ended June 30, 2011

Combined report on the institutions under the control of the Iowa Department of Corrections for the five years ended June 30, 2011

Combined report on the institutions under the control of the Iowa Department of Human Services for the five years ended June 30, 2011

Combined report on the institutions under the control of the Iowa Department of Human Services for the five years ended June 30, 2011

Consumer Advisory: Auto Repairs: Going Under the Hood, April 2013

The Attorney General’s Consumer Protection Division receives hundreds of calls and consumer complaints every year. Follow these tips to avoid unexpected expense and disappointments. This record is about:Auto Repairs: Going Under the Hood

Screening for occupational asthma by using a self-administered questionnaire in a clinical setting

OBJECTIVE: Because of its high prevalence, early screening for occupational asthma (OA) is crucial. We aimed to evaluate the screening performance of the Occupational Asthma Screening Questionnaire-11 items (OASQ-11) in a clinical setting. METHODS: Between January 2009 and December 2011, 169 workers referred for potential OA to our hospital completed the OASQ-11 and underwent workups to determine the final diagnosis. The discriminative abilities of the OASQ-11 as a whole and in relation to demographic and exposure parameters were determined by the area under the receiving operator characteristic curve (AUC). RESULTS: Model 1, consisting of the OASQ's items, showed fair discrimination (AUC, 0.69; 95% confidence interval, 0.58 to 0.80). Addition of age and exposure duration to model 1 improved discrimination (AUC, 0.80; confidence interval, 0.72 to 0.88). CONCLUSION: A simple model consisting of the OASQ-11's items, age, and exposure duration could well discriminate subjects with OA in a clinical setting.

Audit report on the AIM - Jefferson, Keokuk Early Childhood Iowa Area Board, d/b/a Jefferson/Keokuk Early Childhood Iowa Area for the year ended June 30, 2012

Audit report on the AIM - Jefferson, Keokuk Early Childhood Iowa Area Board, d/b/a Jefferson/Keokuk Early Childhood Iowa Area for the year ended June 30, 2012

Audit report on the Taylor County Early Childhood Iowa Area for the year ended June 30, 2012

Audit report on the Taylor County Early Childhood Iowa Area for the year ended June 30, 2012

Combined report on the institutions under the control of the Iowa Department of Human Services for the five years ended June 30, 2012

Combined report on the institutions under the control of the Iowa Department of Human Services for the five years ended June 30, 2012

Combined report on the institutions under the control of the Iowa Department of Corrections for the five years ended June 30, 2012

Combined report on the institutions under the control of the Iowa Department of Corrections for the five years ended June 30, 2012

Ruling out coronary heart disease in primary care: external validation of a clinical prediction rule.

BACKGROUND: The Marburg Heart Score (MHS) aims to assist GPs in safely ruling out coronary heart disease (CHD) in patients presenting with chest pain, and to guide management decisions. AIM: To investigate the diagnostic accuracy of the MHS in an independent sample and to evaluate the generalisability to new patients. DESIGN AND SETTING: Cross-sectional diagnostic study with delayed-type reference standard in general practice in Hesse, Germany. METHOD: Fifty-six German GPs recruited 844 males and females aged ≥ 35 years, presenting between July 2009 and February 2010 with chest pain. Baseline data included the items of the MHS. Data on the subsequent course of chest pain, investigations, hospitalisations, and medication were collected over 6 months and were reviewed by an independent expert panel. CHD was the reference condition. Measures of diagnostic accuracy included the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, likelihood ratios, and predictive values. RESULTS: The AUC was 0.84 (95% confidence interval [CI] = 0.80 to 0.88). For a cut-off value of 3, the MHS showed a sensitivity of 89.1% (95% CI = 81.1% to 94.0%), a specificity of 63.5% (95% CI = 60.0% to 66.9%), a positive predictive value of 23.3% (95% CI = 19.2% to 28.0%), and a negative predictive value of 97.9% (95% CI = 96.2% to 98.9%). CONCLUSION: Considering the diagnostic accuracy of the MHS, its generalisability, and ease of application, its use in clinical practice is recommended.

The Office of Auditor of State's letter reporting the results of its evaluation of whether the Office of Secretary of State may appropriately use funds received under the Help America Vote Act

The Office of Auditor of State's letter reporting the results of its evaluation of whether the Office of Secretary of State may appropriately use funds received under the Help America Vote Act

Audit report on the AIM - Jefferson, Keokuk Early Childhood Iowa (ECI) Area Board, d/b/a Jefferson/Keokuk Early Childhood Iowa Area for the year ended June 30, 2013

Audit report on the AIM - Jefferson, Keokuk Early Childhood Iowa (ECI) Area Board, d/b/a Jefferson/Keokuk Early Childhood Iowa Area for the year ended June 30, 2013

Audit report on the Ringgold County Early Childhood Iowa Area for the year ended June 30, 2013

Audit report on the Ringgold County Early Childhood Iowa Area for the year ended June 30, 2013